Firm at a glance
Valtruis is a platform private equity firm, per its own website [S1].
What they buy
Valtruis appears to concentrate exclusively on healthcare services businesses, based on its publicly disclosed portfolio [S2]. The firm’s holdings span multiple healthcare subsectors including value-based care organizations, specialty care providers, health technology platforms, and care coordination services. The portfolio composition suggests a focus on companies operating at the intersection of clinical care delivery and technology-enabled services.
Portfolio
Healthcare Services
Valtruis’s portfolio includes approximately 14 healthcare services companies as of early 2025 [S2]:
* Wellvana Health
* Jukebox Health
* Skylight Health
* Arbiter
* Wayspring
* TailorCare
* Tuesday Health
* Autonomize
* Nadia Care
* HarmonyCares
* InStride Health
* Atropos Health
* Arbital Health
* Sevaro Health
Recent activity (last 24 months)
* January 2026: Skylight Health acquired Stellation Care [S3]
* August 2025: Acquired Skylight Health [S3]
* September 2025: Completed exit of Wellvana Health [S2]
* April 2025: Wellvana Health acquired by Evolent [S2]
* March 2025: Wellvana Health acquired CVS Health’s MSSP Business [S3]
* September 2025: Sevaro Health funding close [S3]
* July 2025: Arbital Health funding close [S3]
* June 2025: Autonomize AI funding close [S3]
* July 2024: HarmonyCares funding close [S3]
* May 2024: Wayspring, Tuesday Health, and Atropos Health funding closes [S3]
* March 2024: InStride Health funding close [S3]
How this firm fits a seller
Valtruis demonstrates a specialized focus on healthcare services businesses, which may appeal to sellers seeking a buyer with sector-specific expertise. The firm’s recent activity shows both platform acquisitions and add-on transactions, with two add-ons completed in the trailing 12 months per public records. The firm has demonstrated exit capability, having completed at least two exits of Wellvana Health in 2025 [S2]. Healthcare services business owners, particularly those in value-based care, specialty care delivery, or health technology, may find alignment with this buyer’s observed investment pattern.
Sources
[S1] https://www.valtruis.com (as of 2025-01-20)
[S2] https://www.valtruis.com/companies (as of 2025-01-20)
[S3] https://www.valtruis.com/news (as of 2025-01-20)
Frequently asked questions
Does Valtruis buy Healthcare Services businesses?
Yes, Valtruis appears to invest exclusively in healthcare services businesses based on its publicly disclosed portfolio [S2]. All 14 portfolio companies listed on the firm’s website operate in healthcare services sectors including value-based care, specialty care, and health technology platforms.
What companies has Valtruis acquired recently?
Recent acquisitions include Skylight Health in August 2025 and the CVS Health MSSP Business (added to Wellvana Health) in March 2025 [S3]. The firm also completed funding closes for Sevaro Health, Arbital Health, and Autonomize AI during 2025 [S3].
Where is Valtruis based and how big is the firm?
The firm’s headquarters location and fund size are not disclosed in publicly available materials reviewed as of January 2025 [S1]. The firm maintains a portfolio of approximately 14 healthcare services companies per its website [S2].
Is Valtruis still actively acquiring?
Yes, Valtruis appears to remain active, with its most recent disclosed transaction occurring in January 2026 when Skylight Health acquired Stellation Care [S3]. The firm completed multiple acquisitions and funding closes throughout 2024 and 2025.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.